276 research outputs found
Density inhomogeneities and Rashba spin-orbit coupling interplay in oxide interfaces
There is steadily increasing evidence that the two-dimensional electron gas
(2DEG) formed at the interface of some insulating oxides like LaAlO3/SrTiO3 and
LaTiO3/SrTiO3 is strongly inhomogeneous. The inhomogeneous distribution of
electron density is accompanied by an inhomogeneous distribution of the
(self-consistent) electric field confining the electrons at the interface. In
turn this inhomogeneous transverse electric field induces an inhomogeneous
Rashba spin-orbit coupling (RSOC). After an introductory summary on two
mechanisms possibly giving rise to an electronic phase separation accounting
for the above inhomogeneity,we introduce a phenomenological model to describe
the density-dependent RSOC and its consequences. Besides being itself a
possible source of inhomogeneity or charge-density waves, the density-dependent
RSOC gives rise to interesting physical effects like the occurrence of
inhomogeneous spin-current distributions and inhomogeneous quantum-Hall states
with chiral "edge" states taking place in the bulk of the 2DEG. The
inhomogeneous RSOC can also be exploited for spintronic devices since it can be
used to produce a disorder-robust spin Hall effect.Comment: 13 pages, 15 figure
Prognostic implication of stress echocardiography in 6214 hypertensive and 5328 normotensive patients
n/
Comparison Between the Biomechanical Responses of the Hand and Foot When Exposed to Vertical Vibration
Workers can be exposed daily to foot-transmitted vibration (FTV) from standing on mobile equipment or vibrating platforms and surfaces. This results in a consistent risk of developing neurological, vascular, and musculoskeletal problems. To date, there are no international stand-ards describing procedures with which to evaluate the health risks deriving from long-term ex-posure to FTV. To study the applicability of hand–arm vibration (HAV) standards to the foot, the biomechanical responses of the hand and foot in terms of the frequency response function upon varying contact conditions were compared. Results evidenced similarities between the responses of the wrist and ankle, with differences in resonance for the fingers and toes. The study confirms that HAV standards are more suitable than whole-body vibration standards for evaluating higher frequency exposure to FTV
Circulating microRNAs found dysregulated in ex-exposed asbestos workers and pleural mesothelioma patients as potential new biomarkers
Malignant pleural mesothelioma (MPM), a fatal cancer, is an occupational disease mostly affecting workers ex-exposed to asbestos fibers. The asbestos, a cancerogenic mineral of different chemical composition, was widely employed in western Countries in industrial manufactures of different types. MPM may arise after a long latency period, up to five decades. MPM is resistant to conventional chemo- and radio-therapies. Altogether, these data indicate that the identification of new and specific markers are of a paramount importance for an early diagnosis and treatment of MPM. In recent years, microRNAs expression was found dysregulated in patients, both in cancer cells and sera, affected by tumors of different histotypes, including MPM. Cell and circulanting microRNAs, found to be dysregulated in this neoplasia, were proposed as new biomarkers. It has been reported that circulating microRNAs are stable in biological fluids and could be employed as potential MPM biomarkers. In this investigation, circulating microRNAs (miR) from serum samples of MPM patients and workers ex-exposed to asbestos fibers (WEA) and healthy subjects (HS) were comparatively analyzed by microarray and RT-qPCR technologies. Our results allowed (i) to select MiR-3665, an endogenous stable microRNA, as the internal control to quantify in our analyses circulating miRNAs; to detect (ii) miR-197-3p, miR-1281 and miR 32-3p up-regulated in MPM compared to HS; (iii) miR-197-3p and miR-32-3p up-regulated in MPM compared to WEA; (iv) miR-1281 up-regulated in both MPM and WEA compared to HS. In conclusion, three circulating up-regulated microRNAs, i.e. miR-197-3p, miR-1281 and miR-32-3p are proposed as potential new MPM biomarker
A Modified Protocol for Bisulfite Genomic Sequencing of Difficult Samples
The bisulfite genomic sequencing protocol is a widely used method for analyzing DNA methylation. It relies on the deamination of unmethylated cytosine residues to uracil; however, its high rates of DNA degradation and incomplete cytosine to uracil conversion often lead to failed experiments, uninformative results, and false positives. Here, we report the addition of a single-step multiple restriction enzyme digestion (MRED) designed to differentially digest polymerase chain reaction products amplified from unconverted DNA while leaving those of converted DNA intact. We show that for our model system, RARB2 P2 promoter, use of MRED increased informative sequencings ninefold, and MRED did not alter the clonal representation in one fully methylated cell line, H-596, treated or not with 5-azadeoxycytidine, a methylation inhibitor. We believe that this method may easily be adapted for analyzing other genes and provide guidelines for selecting the most appropriate MRED restriction enzymes
Clinical correlates of complicated grief among individuals with acute coronary syndromes
OBJECTIVE:
The study aimed at exploring bereavement and complicated grief (CG) symptoms among subjects without a history of coronary heart disease (CHD) at the time of a first acute coronary syndrome (ACS) and to evaluate the relationship of CG symptoms and ACS.
METHOD:
Overall, 149 subjects with ACS (namely, acute myocardial infarct with or without ST-segment elevation or unstable angina), with no previous history of CHD, admitted to three cardiac intensive care units were included and evaluated by the Structured Clinical Interview for Complicated Grief (SCI-CG), Hamilton Depression Rating Scale, Hamilton Anxiety Rating Scale, and the 36-item Short-Form Health Survey (MOS-SF-36).
RESULTS:
Of the total sample of 149 subjects with ACS, 118 (79.2%) met criteria for DSM-5 persistent complex bereavement disorder. Among these, subjects who lost a partner, child, or sibling were older (P=0.008), less likely to be working (P=0.032), and more likely to be suffering from hypertension (P=0.021), returned higher scores on the SCI-CG (P=0.001) and developed the index ACS more frequently between 12 and 48 months after the death than those who lost a parent or another relative (P≤0.0001). The occurrence of ACS 12-48 months (P=0.019) after the loss was positively correlated with SCI-CG scores. An inverse relationship with SCI-CG scores was observed for patients who experienced ACS more than 48 months after the loss (P=0.005). The SCI-CG scores significantly predicted lower scores on the "general health" domain of MOS-SF-36 (P=0.030), as well as lower scores on "emotional well-being" domain (P=0.010).
CONCLUSION:
A great proportion of subjects with ACS report the loss of a loved one. Among these, the loss of a close relative and the severity of CG symptoms are associated with poorer health status. Our data corroborate previous data indicating a strong relationship between CG symptoms and severe cardiac problems
Risk Factors for operated carpal tunnel syndrome: a multicenter population-based case-control study
This article is available from: http://www.biomedcentral.com/1471-2458/9/34
S100A6 (Calcyclin) is a prostate basal cell marker absent in prostate cancer and its precursors
S100A6 (Calcyclin) is a calcium-binding protein that has been implicated in a variety of biological functions as well as tumorigenesis.
The aim of our study was to investigate the involvement of S100A6 during prostate cancer development and progression. Using
immunohistochemistry, the expression of S100A6 was examined in benign (n ¼ 66), premalignant (n ¼ 10), malignant (n ¼ 66) and
metastatic prostate (n ¼ 5) tissues arranged in a tissue-microarray or whole sections as well as in prostate cancer cell lines. The
S100A6 immunostaining pattern in tissues was compared with that of cytokeratin 5 (a basal cell marker) and 18 (a benign luminal cell
marker). In all cases of benign epithelium, intense S100A6 expression was seen in the basal cell layer with absent staining in luminal
cells. In all cases of prostatic adenocarcinoma (matched), metastatic lesions and 3/10 high-grade prostatic intraepithelial neoplasia
lesions, an absence of S100A6 was seen. Western blotting and RT–PCR analysis of cell lines showed S100A6 expression to be
absent in LNCaP, LNCaP-LN3 and LNCaP-Pro5 but present in Du145, PC3, PC-3M and PC-3M-LN4. LNCaP cells treated with 5-
Azacytidine, caused re-expression of S100A6 mRNA. Sequencing of bisulphite modified DNA showed CpG methylation within the
S100A6 promoter region and exon 1 of LNCaP, LNCaP-LN3 and LNCaP-Pro5 cell lines but not in Du145 cells. Our data suggest
that loss of S100A6 protein expression is common in prostate cancer development and may occur at an early stage. The mechanism
of loss of expression may involve hypermethylation of CpG sites. The finding of intense S100A6 expression in the basal cells of benign
glands but loss of expression in cancer could be useful as a novel diagnostic marker for prostate cancer
Assessing functional mitral regurgitation with exercise echocardiography: rationale and clinical applications
Secondary or functional mitral regurgitation (FMR) represents an increasing feature of mitral valve disease characterized by abnormal function of anatomically normal leaflets in the context of the impaired function of remodelled left ventricles. The anatomic and pathophysiological basis of FMR are briefly analyzed; in addition, the role of exercise echocardiography for the assessment of FMR is discussed in view of its relevance to clinical practice
Exposição combinada entre ruÃdo e vibração e seus efeitos sobre a audição de trabalhadores
- …